Upregulation of Rpn10 promotes tumor progression via activation of the NF-κB pathway in clear cell renal cell carcinoma
- PMID: 34133712
- DOI: 10.1093/abbs/gmab078
Upregulation of Rpn10 promotes tumor progression via activation of the NF-κB pathway in clear cell renal cell carcinoma
Abstract
The ubiquitin-proteasome system (UPS) plays a central role in regulating protein homeostasis in tumor progression. The proteasome subunit Rpn10 is associated with the progression of several tumor types. However, little is known regarding the role of Rpn10 in clear cell renal cell carcinoma (ccRCC). In this study, we found that overexpression of Rpn10 increased ccRCC cell proliferation, migration, and invasion. Silencing Rpn10 expression resulted in decreased cell proli-feration, migration, and invasion in ccRCC cells. Knockdown of Rpn10 inhibits tumor growth and cell proliferation in vivo. Furthermore, we demonstrated that Rpn10 increased cell proliferation, migration, and invasion via regulation of the nuclear factor kappa B (NF-κB) pathway. Rpn10 directly promoted inhibitor of nuclear factor-kappa B alpha (IκBα) degradation through the UPS. Moreover, we observed that upregulation of Rpn10 or downregulation of IκBα in ccRCC was associated with poor prognosis. We found that the combination of these two parameters was a more powerful predictor of poor prognosis than either parameter alone. Collectively, these findings provide evidence that Rpn10 promotes the progression of ccRCC by regulation of the NF-κB pathways and is a prognostic indicator for patients with ccRCC.
Keywords: NF-κB; Rpn10; clear cell renal cell carcinoma; prognosis.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma.Cancer Lett. 2019 Apr 10;447:1-11. doi: 10.1016/j.canlet.2019.01.020. Epub 2019 Jan 20. Cancer Lett. 2019. PMID: 30673593
-
Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation.Cancer Med. 2021 Jun;10(11):3674-3688. doi: 10.1002/cam4.3911. Epub 2021 May 11. Cancer Med. 2021. PMID: 33973730 Free PMC article.
-
CARMA3 Transcriptional Regulation of STMN1 by NF-κB Promotes Renal Cell Carcinoma Proliferation and Invasion.Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211027915. doi: 10.1177/15330338211027915. Technol Cancer Res Treat. 2021. PMID: 34190011 Free PMC article.
-
GYS1 induces glycogen accumulation and promotes tumor progression via the NF-κB pathway in Clear Cell Renal Carcinoma.Theranostics. 2020 Jul 14;10(20):9186-9199. doi: 10.7150/thno.46825. eCollection 2020. Theranostics. 2020. PMID: 32802186 Free PMC article.
-
The molecular mechanism of NF-κB dysregulation across different subtypes of renal cell carcinoma.J Adv Res. 2025 Jun;72:501-514. doi: 10.1016/j.jare.2024.07.030. Epub 2024 Jul 31. J Adv Res. 2025. PMID: 39094893 Free PMC article. Review.
Cited by
-
Overexpression CPT1A reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC.Acta Biochim Biophys Sin (Shanghai). 2022 Jan 25;54(2):220-231. doi: 10.3724/abbs.2021023. Acta Biochim Biophys Sin (Shanghai). 2022. PMID: 35130611 Free PMC article.
-
Ubiquitin receptors play redundant roles in the proteasomal degradation of the p53 repressor MDM2.FEBS Lett. 2022 Nov;596(21):2746-2767. doi: 10.1002/1873-3468.14436. Epub 2022 Jul 21. FEBS Lett. 2022. PMID: 35735670 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical